| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| CD206 | HOT CD6-M52H7 | Mouse CD206 / MMR Protein, His Tag (HPLC verified) | Mouse | HEK293 | ![]() | HPLCSDS-PAGE | $380.00 100ug | ||
| CD206 | HOTAvitag CD6-H82E4 | Biotinylated Human CD206 / MMR Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $350.00 25ug | ||
| CD206 | HOT CD6-H82H6 | Biotinylated Human CD206 / MMR Protein, His Tag, ultra sensitivity (primary amine labeling) (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $345.00 25ug | ||
| CD206 | HOT CD6-H52H9 | Human CD206 / MMR Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $435.00 100ug | ||
| CD206 | Cynomolgus CD206 / MMR Protein, His Tag (MALS verified) | Cynomolgus | HEK293 | MALSSDS-PAGE | $380.00 100ug | ||||
| CD206 | Avitag CD6-C82E4 | Biotinylated Cynomolgus CD206 / MMR Protein, His,Avitag™ (MALS verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | ||
| CD206 | Avitag CD6-M82E8 | Biotinylated Mouse CD206 / MMR Protein, His,Avitag™ (HPLC verified) | Mouse | HEK293 | ![]() | HPLCSDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| 68Ga-tilmanocept | Phase 3 Clinical | Navidea Biopharmaceuticals Inc | Atherosclerosis; Carcinoma, Endometrioid; Endometrial Neoplasms; Tuberculosis | Details | |
| 68GaNOTA-Anti-MMR-VHH2 | Phase 2 Clinical | Universitair Ziekenhuis Brussel | Atherosclerosis; Carcinoma, Non-Small-Cell Lung; Carotid Stenosis; Hodgkin Disease; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Non-Hodgkin; Neoplasms; Sarcoidosis | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Technetium Tc 99m tilmanocept | NEO3-09 | Approved | University Of California | Lymphoseek Kit, Lymphoseek, Lymphoaim | United States | Solid tumours; Diagnostic agents; Breast Neoplasms; Melanoma; Carcinoma, Squamous Cell; Head and Neck Neoplasms | Cardinal Health 414 Llc | 2013-03-13 | Anus Neoplasms; Arthritis, Rheumatoid; Breast Neoplasms; Carcinoma, Squamous Cell; Central Nervous System Neoplasms; Colonic Neoplasms; Colorectal Neoplasms; Diagnostic agents; Endometrial Neoplasms; Head and Neck Neoplasms; HIV Infections; Liver Neoplasms; Melanoma; Metabolic Dysfunction-Associated Steatotic Liver Disease; Rectal Neoplasms; Sarcoidosis; Sarcoma, Kaposi; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms | Details |